Genta To File Complaint With FDA Over Statistical Analysis Of Genasense Data

Complaint relates to 2004 analysis of Genasense progression-free survival data in melanoma, presented to the Oncologic Drugs Advisory Committee.

More from Archive

More from Pink Sheet